I 

118TH CONGRESS 

2D SESSION H. R. 9782 

To direct the Secretary of Health and Human Services to study and report 

on the relationship between hair straighteners and uterine cancer, particularly among women of color. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 24, 2024 

Ms. CLARKE of New York (for herself, Ms. BROWN, Mrs. WATSON COLEMAN, 

Ms. ADAMS, Mrs. BEATTY, Ms. BLUNT ROCHESTER, Mrs. CHERFILUSMCCORMICK, Ms. CROCKETT, Mr. DAVIS of North Carolina, Mrs. 

FLETCHER, Mrs. FOUSHEE, Ms. NORTON, Ms. KELLY of Illinois, Ms. 

LEE of California, Ms. LOFGREN, Mrs. MCBATH, Ms. MCCLELLAN, Mr. 

MEEKS, Ms. PLASKETT, Ms. SEWELL, Mr. BISHOP of Georgia, Mr. CARTER of Louisiana, Ms. VELA ́ZQUEZ, Ms. WILLIAMS of Georgia, Ms. WILSON of Florida, Ms. WASSERMAN SCHULTZ, and Mr. TONKO) introduced 

the following bill; which was referred to the Committee on Energy and 

Commerce 

A BILL 

To direct the Secretary of Health and Human Services to 

study and report on the relationship between hair 

straighteners and uterine cancer, particularly among 

women of color. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 9782 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Uterine Cancer Study 

3 Act of 2024’’. 

4 SEC. 2. STUDY ON RELATIONSHIP BETWEEN HAIR 

5 STRAIGHTENERS AND UTERINE CANCER. 

6 (a) STUDY.—The Secretary of Health and Human 

7 Services, in coordination with the Commissioner of Food 

8 and Drugs and the Director of the National Institutes of 

9 Health, shall conduct a study on the relationship between 

10 hair straighteners and uterine cancer, with a focus on the 

11 increased incidence of such cancer among women of color. 

12 Such study shall— 

13 (1) review significant findings and recommenda14 tions from other studies regarding the relationship 

15 between hair straighteners and uterine cancer; 

16 (2) consider impacts on women and other indi17 viduals at risk of uterine cancer from all racial and 

18 ethnic backgrounds; 

19 (3) disaggregate the results of the study under 

20 this section according to whether the hair straight21 eners contain dyes or coloring, bleach, highlights, or 

22 perms; and 

23 (4) determine whether the Food and Drug Ad24 ministration should impose additional testing re25 quirements on the manufacturers of hair straightVerDate Sep 11 2014 05:04 Oct 08, 2024 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H9782.IH H9782

kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 9782 IH

1 ening products to ensure the safety of such prod2 ucts. 

3 (b) METHODOLOGY.—Not later than 45 days after 

4 the date of enactment of this Act, the Secretary shall sub5 mit to the Committee on Energy and Commerce of the 

6 House of Representatives and the Committee on Health, 

7 Education, Labor, and Pensions of the Senate a descrip8 tion of the methodology that will be used to conduct the 

9 study under this section. 

10 (c) COMMENCEMENT.—Not later than 180 days after 

11 the date of enactment of this Act, the Secretary shall com12 mence the study under this section. 

13 (d) REPORT.—Not later than 2 years after the date 

14 of enactment of this Act, the Secretary shall complete the 

15 study under this section and submit to the Committee on 

16 Energy and Commerce of the House of Representatives 

17 and the Committee on Health, Education, Labor, and 

18 Pensions of the Senate a report on the results of such 

19 study. 

20 (e) DEFINITION.—In this section: 

21 (1) The term ‘‘hair straightener’’ means a 

22 chemical hair straightener. 

23 (2) The term ‘‘Secretary’’ means the Secretary 

24 of Health and Human Services. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB